Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 2000 Feb;84(2):144–149. doi: 10.1136/bjo.84.2.144

A systematic review of drug induced ocular reactions in diabetes

J Hampson 1, J Harvey 1
PMCID: PMC1723374  PMID: 10655188

Abstract

AIMS—To conduct a systematic review of drug induced adverse ocular effects in diabetes to determine if this approach identified any previously unrecognised adverse drug effects; to make a preliminary assessment of the feasibility of this approach in identifying adverse drug reactions; and to assess the current accessibility of this information to prescribing physicians.
METHODS—Literature search of online biomedical databases. The search strategy linked eye disorders with adverse drug reactions and diabetes. Source journals were classified as medical, pharmaceutical, diabetes related, or ophthalmological. It was determined whether the reactions identified were recorded in drug datasheets and the British National Formulary.
RESULTS—63 references fulfilled the selection criteria, of which 45 were considered to be relevant to the study. The majority of these were case reports but cross sectional surveys, case-control and cohort studies, and review articles were also identified. 61% of the reactions were not recorded in the British National Formulary and 41% were not recorded in the datasheets. 55% appeared in specialist ophthalmology journals.
CONCLUSIONS—This is a feasible approach to the identification of adverse drug reactions. Adverse reactions not listed in the most commonly used reference sources were found. The majority were published in specialist ophthalmology journals which might not be seen by prescribing physicians.



Full Text

The Full Text of this article is available as a PDF (119.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caramelli B., Tranchesi B., Jr, Gebara O. C., de Sa L. C., Pileggi F. J. Retinal haemorrhage after thrombolytic therapy. Lancet. 1991 Jun 1;337(8753):1356–1357. doi: 10.1016/0140-6736(91)93043-9. [DOI] [PubMed] [Google Scholar]
  2. Chylack L. T., Jr Cataracts and inhaled corticosteroids. N Engl J Med. 1997 Jul 3;337(1):46–48. doi: 10.1056/NEJM199707033370110. [DOI] [PubMed] [Google Scholar]
  3. Clair W. K., Chylack L. T., Jr, Cook E. F., Goldman L. Allopurinol use and the risk of cataract formation. Br J Ophthalmol. 1989 Mar;73(3):173–176. doi: 10.1136/bjo.73.3.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cumming R. G., Mitchell P., Leeder S. R. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med. 1997 Jul 3;337(1):8–14. doi: 10.1056/NEJM199707033370102. [DOI] [PubMed] [Google Scholar]
  5. Davis J. L., Taskintuna I., Freeman W. R., Weinberg D. V., Feuer W. J., Leonard R. E. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol. 1997 Jun;115(6):733–737. doi: 10.1001/archopht.1997.01100150735008. [DOI] [PubMed] [Google Scholar]
  6. Dukar O., Barr C. C. Visual loss complicating OKT3 monoclonal antibody therapy. Am J Ophthalmol. 1993 Jun 15;115(6):781–785. doi: 10.1016/s0002-9394(14)73648-7. [DOI] [PubMed] [Google Scholar]
  7. Filipović T., Bujanić-Cuculić S., Bosković I. Ostećenje vidnog zivca pri uporabi etambutola. Lijec Vjesn. 1997 Nov;119(10):273–274. [PubMed] [Google Scholar]
  8. Fraunfelder F. T. National Registry of Drug-Induced Ocular Side Effects. Am J Ophthalmol. 1990 Oct 15;110(4):426–427. doi: 10.1016/s0002-9394(14)77027-8. [DOI] [PubMed] [Google Scholar]
  9. Garbe E., LeLorier J., Boivin J. F., Suissa S. Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids. Lancet. 1997 Oct 4;350(9083):979–982. doi: 10.1016/S0140-6736(97)03392-8. [DOI] [PubMed] [Google Scholar]
  10. Garg S. K., Chase H. P., Marshall G., Hoops S. L., Holmes D. L., Jackson W. E. Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA. 1994 Apr 13;271(14):1099–1102. [PubMed] [Google Scholar]
  11. Goldberg L. D., Alterman S. L. Concurrent hypoglycemia and lactic acidosis in a diabetic treated with chlorpropamide and phenformin. South Med J. 1973 Feb;66(2):190–192. doi: 10.1097/00007611-197302000-00004. [DOI] [PubMed] [Google Scholar]
  12. Grekos Z. G., Schocken D. D. Bilateral vitreous hemorrhages as a consequence of thrombolytic therapy successfully treated with vitrectomy in a patient without diabetes. Am Heart J. 1995 Sep;130(3 Pt 1):611–612. doi: 10.1016/0002-8703(95)90371-2. [DOI] [PubMed] [Google Scholar]
  13. Greven C. M., Slusher M. M., Weaver R. G. Retinal arterial occlusions in young adults. Am J Ophthalmol. 1995 Dec;120(6):776–783. doi: 10.1016/s0002-9394(14)72731-x. [DOI] [PubMed] [Google Scholar]
  14. Hamill M. B., Suelflow J. A., Smith J. A. Transdermal scopolamine delivery system (TRANSDERM-V) and acute angle-closure glaucoma. Ann Ophthalmol. 1983 Nov;15(11):1011–1012. [PubMed] [Google Scholar]
  15. Isaac N. E., Walker A. M., Jick H., Gorman M. Exposure to phenothiazine drugs and risk of cataract. Arch Ophthalmol. 1991 Feb;109(2):256–260. doi: 10.1001/archopht.1991.01080020102053. [DOI] [PubMed] [Google Scholar]
  16. Jimenez-Lucho V. E., del Busto R., Odel J. Isoniazid and ethambutol as a cause of optic neuropathy. Eur J Respir Dis. 1987 Jul;71(1):42–45. [PubMed] [Google Scholar]
  17. Jude E. B., Ryan B., O'Leary B. M., Gibson J. M., Dodson P. M. Pupillary dilatation and driving in diabetic patients. Diabet Med. 1998 Feb;15(2):143–147. doi: 10.1002/(SICI)1096-9136(199802)15:2<143::AID-DIA531>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  18. Kawano T., Shigehira M., Uto H., Nakama T., Kato J., Hayashi K., Maruyama T., Kuribayashi T., Chuman T., Futami T. Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol. 1996 Feb;91(2):309–313. [PubMed] [Google Scholar]
  19. Keller J. T. Second generation oral hypoglycemic agents. J Am Optom Assoc. 1991 Jul;62(7):513–514. [PubMed] [Google Scholar]
  20. Kirwan J. F., Tsaloumas M. D., Vinall H., Prior P., Kritzinger E. E., Dodson P. M. Sex hormone preparations and retinal vein occlusion. Eye (Lond) 1997;11(Pt 1):53–56. doi: 10.1038/eye.1997.11. [DOI] [PubMed] [Google Scholar]
  21. Klein B. E., Moss S. E., Klein R. Oral contraceptives in women with diabetes. Diabetes Care. 1990 Aug;13(8):895–898. doi: 10.2337/diacare.13.8.895. [DOI] [PubMed] [Google Scholar]
  22. Lakowski R., Morton A. Acquired colour losses and oral contraceptives. Mod Probl Ophthalmol. 1978;19:314–318. [PubMed] [Google Scholar]
  23. Lakowski R., Morton A. The effect of oral contraceptives on colour vision in diabetic women. Can J Ophthalmol. 1977 Apr;12(2):89–97. [PubMed] [Google Scholar]
  24. Leske M. C., Chylack L. T., Jr, Wu S. Y. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol. 1991 Feb;109(2):244–251. doi: 10.1001/archopht.1991.01080020090051. [DOI] [PubMed] [Google Scholar]
  25. Lightman J. M., Townsend J. C., Selvin G. J. Ocular effects of second generation oral hypoglycemic agents. J Am Optom Assoc. 1989 Nov;60(11):849–853. [PubMed] [Google Scholar]
  26. Liu C. S., Leonard T. J., Brown N. A. The lens opacities case-control study. Arch Ophthalmol. 1991 Dec;109(12):1635–1636. doi: 10.1001/archopht.1991.01080120013004. [DOI] [PubMed] [Google Scholar]
  27. Maddox K. Blindness due to an anticoagulant. Med J Aust. 1977 Mar 19;1(12):420–420. doi: 10.5694/j.1326-5377.1977.tb130779.x. [DOI] [PubMed] [Google Scholar]
  28. Miller N. R., Moses H. Transient oculomotor nerve palsy. Association with thiazide-induced glucose intolerance. JAMA. 1978 Oct 20;240(17):1887–1888. [PubMed] [Google Scholar]
  29. Novack G. D. Ocular toxicology. Curr Opin Ophthalmol. 1994 Dec;5(6):110–114. doi: 10.1097/00055735-199412000-00018. [DOI] [PubMed] [Google Scholar]
  30. Paterson C. A. Effects of drugs on the lens. Int Ophthalmol Clin. 1971;11(2):63–97. [PubMed] [Google Scholar]
  31. Pfefferman R., Gombos G. M., Kountz S. L. Ocular complications after renal transplantation. Ann Ophthalmol. 1977 Apr;9(4):467-70, 473. [PubMed] [Google Scholar]
  32. Renfro L., Snow J. S. Ocular effects of topical and systemic steroids. Dermatol Clin. 1992 Jul;10(3):505–512. [PubMed] [Google Scholar]
  33. Sedwick L. A. Getting to the heart of visual loss: when cardiac medication may be dangerous to the optic nerves. Surv Ophthalmol. 1992 Mar-Apr;36(5):366–372. doi: 10.1016/0039-6257(92)90114-9. [DOI] [PubMed] [Google Scholar]
  34. Shyan W. J. Anticoagulation, antiplatelets and ocular haemorrhage. Singapore Med J. 1997 Jun;38(6):279–279. [PubMed] [Google Scholar]
  35. Sorensen P. N. Transitory blindness during ethanol and phenethylbiguanide induced lactic acidosis in a subject with diabetes mellitus. A case report. Acta Ophthalmol (Copenh) 1977 Apr;55(2):177–182. doi: 10.1111/j.1755-3768.1977.tb01298.x. [DOI] [PubMed] [Google Scholar]
  36. Sponsel W. E., Rapoza P. A. Posterior subcapsular cataract associated with indapamide therapy. Arch Ophthalmol. 1992 Apr;110(4):454–454. doi: 10.1001/archopht.1992.01080160032015. [DOI] [PubMed] [Google Scholar]
  37. Steinberg H., Saravay S. M., Wadhwa N., Pollack S., Maesaka J. Erythropoietin and visual hallucinations in patients on dialysis. Psychosomatics. 1996 Nov-Dec;37(6):556–563. doi: 10.1016/S0033-3182(96)71519-0. [DOI] [PubMed] [Google Scholar]
  38. Wymore J., Carter J. E. Chlorpropamide-induced optic neuropathy. Arch Intern Med. 1982 Feb;142(2):381–381. [PubMed] [Google Scholar]
  39. Yablonski M. E., Burde R. M., Kolker A. E., Becker B. Cataracts induced by topical dexamethasone in diabetics. Arch Ophthalmol. 1978 Mar;96(3):474–476. doi: 10.1001/archopht.1978.03910050250011. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES